• For Individuals
  • For Institutions
  • Download
  • Help
  • About

longbridgelongbridge
longbridgelongbridge
Why Longbridge?
Investment Products
Trading Tools
Trading Platform
Developers
Market Data Services
Analysis Tools
News Services
Dolphin Research
Pricing
Markets
Global Markets
Stock Screener
Information
Research
News
Live
Community
Academy
Promotions
PortAI
LB Café
EN
English
简体中文
繁體中文
繁體中文(廣東話)Posts & comments will be shown in Cantonese
Search...
Quote ListQuote List
Overview
Posts
News
Financials
© 2025 Longbridge|Disclaimer

Event Tracking

Oct23
Lishengpharma released FY2025 9 Months Earnings on October 23 After-Market (BJT), with actual revenue of CNY 1.007 B and EPS of CNY 1.4577
01:00
Lishengpharma released FY2025 Q3 earnings on October 23 After-Market BJT, actual revenue CNY 275.77 M, actual EPS CNY 0.1083
01:00
Oct16
Lishengpharma FY2025 Q3 Earnings Release on October 24, 2025 After-Market (BJT)
00:26
Aug21
Lishengpharma released FY2025 Semi-Annual Earnings on August 21 After-Market BJT, actual revenue CNY 731.51 M, actual EPS CNY 1.33
01:00
Lishengpharma released FY2025 Q2 earnings on August 21 After-Market (BJT), actual revenue CNY 361.67 M, actual EPS CNY 1.1393
01:00
Aug14
Lishengpharma to Release FY2025 Semi-Annual Earnings on August 22, 2025 (BJT)
00:26

Schedules & Filings

Schedules
Filings
Oct23
Earning Release(CST)

FY2025 Q3 Earning Release (CNY) Revenue 275.77 M, Net Income 27.82 M, EPS 0.1083

Aug22
Earning Release(CST)

FY2025 Semi-Annual Earning Release

Aug21
Earning Release(CST)

FY2025 Q2 Earning Release (CNY) Revenue 361.67 M, Net Income 287.65 M, EPS 1.1393

View More

Stock List

Top Gainers
Top Decliners
Northbound Connect
Symbol
Price
%Chg
Change
View More